Patient specific drug sensitivity to novel treatment approaches in ovarian cancer ex vivo 3D tumor cultures

被引：0
|
作者：
Grillet, Fanny [1 ]
Jariani, Abbas [2 ]
Overkamp, Juul [1 ]
Daszkiewicz, Lidia [1 ]
Yan, Kuan [1 ]
Price, Leo [1 ]
Vader, Willemijn [2 ]
机构：
[1] OcellO BV, Leiden, Netherlands
[2] VitroScan BV, Leiden, Netherlands
来源：
MOLECULAR CANCER THERAPEUTICS | 2019年 / 18卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-19-B139
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B139
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Ovarian cancer ex vivo 3D tumor cultures predict patient specific drug sensitivity
    Grillet, Fanny
    Jariani, Abbas
    Overkamp, Juul
    Daszkiewicz, Lidia
    Yan, Kuan
    Price, Leo S.
    Vader, Willemijn
    CANCER RESEARCH, 2020, 80 (16)
  • [2] Predicting drug sensitivity in patient derived ex vivo 3D mesothelioma cultures
    Cornelissen, Robin
    Dumouline, Daphne
    Thusen, Janvd
    Basten, Sander
    Grillet, Fanny
    Yan, Kuan
    Price, Leo
    Vader, Willemijn
    CANCER RESEARCH, 2019, 79 (13)
  • [3] Predicting PARPi sensitivity in patient derived ex vivo 3D tumor cultures
    Basten, Sander
    Herpers, Bram
    Yan, Kuan
    Vader, Willemijn
    Price, Leo
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [4] Predicting PARPi sensitivity in patient derived ex vivo 3D tumour cultures
    Basten, S.
    Overkamp, J.
    Herpers, B.
    Yan, K.
    Price, L.
    Vader, W.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E104 - E104
  • [5] Ovarian Cancer Treatment Stratification Using Ex Vivo Drug Sensitivity Testing
    Lohse, Ines
    Azzam, Diana J.
    Al-Ali, Hassan
    Volmar, Claude-Henry
    Brothers, Shaun P.
    Ince, Tan A.
    Wahlestedt, Claes
    ANTICANCER RESEARCH, 2019, 39 (08) : 4023 - 4030
  • [6] Development of the drug efficacy testing in ex vivo 3D cultures (DETECT) platform and its application to functional precision medicine in ovarian cancer
    Akerlund, Emma
    Gudoityte, Greta
    Lamodiere, Elisabeth Moussaud
    Carlson, Joseph
    Wallin, Emelie
    Fernebro, Josefin
    Kallioniemi, Olli
    Ostling, Paivi
    Joneborg, Ulrika
    Seashore-Ludlow, Brinton
    CANCER RESEARCH, 2022, 82 (12)
  • [7] Protocol for quantifying drug sensitivity in 3D patient- derived ovarian cancer models
    Labrosse, Kathrin B.
    Lombardo, Flavio C.
    Rimmer, Natalie
    Lopez, Monica Nunez
    Fedier, Andre
    Heinzelmann-Schwarz, Viola
    Coelho, Ricardo
    Jacob, Francis
    STAR PROTOCOLS, 2024, 5 (03):
  • [8] 3D EX VIVO PATIENT TISSUE PLATFORM FOR IMMUNOONCOLOGY DRUG TESTING
    Basten, Sander
    Beztsinna, Nataliia
    Grillet, Fanny
    Yan, Kuan
    Meesters, Niels
    van der Meer, Donny
    Spanjaard, Emma
    Vader, Willemijn
    Price, Leo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A212 - A212
  • [9] Novel patient avatar platform for oncology drug testing using 3D ex vivo models derived from fresh patient tumor tissues
    Beztsinna, Nataliia
    Grillet, Fanny
    Meesters, Niels
    van der Meer, Donny
    Daszkiewicz, Lidia
    Yan, Kuan
    Spanjaard, Emma
    Vader, Willemijn
    Price, Leo
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [10] Development of an Ex Vivo 3D Functional Assay for Novel Drug Discoveries
    Murali, Vasanth Siruvallur
    Danuser, Gaudenz
    Cobanoglu, Murat Can
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
12345